Detalles de la búsqueda
1.
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
Alzheimers Dement
; 20(4): 2698-2706, 2024 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-38400532
2.
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease.
Hum Brain Mapp
; 44(18): 6375-6387, 2023 Dec 15.
Artículo
Inglés
| MEDLINE | ID: mdl-37867465
3.
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Alzheimers Dement (Amst)
; 14(1): e12367, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-36348972
Resultados
1 -
3
de 3
1
Próxima >
>>